ClinicalTrials.Veeva

Menu

Soy Isoflavone Tablets: Effects on Sleep, Quality of Life, Symptoms and Cognitive Function in Menopausal Women

Mass General Brigham logo

Mass General Brigham

Status and phase

Completed
Phase 4

Conditions

Hot Flashes

Treatments

Drug: soy isoflavones
Drug: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT01401946
99-004-P

Details and patient eligibility

About

The study was done to elucidate relationships between midlife women's self-reported hot flashes, neuropsychological symptoms, cognitive performance or sleep.

Enrollment

88 patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • At least 5 hot flash episodes and/or night sweats per 24 hours

Exclusion criteria

  • Body mass index (BMI) more than 34 kg/m2
  • Hypertension
  • Shift work
  • Psychiatric or medical conditions that would affect outcome measures
  • More than 4 caffeine drinks per day
  • More than 10 cigarettes per day
  • More than than 7 alcohol drinks per week

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

88 participants in 2 patient groups, including a placebo group

soy isoflavones
Active Comparator group
Treatment:
Drug: soy isoflavones
Placebo
Placebo Comparator group
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems